Roivant Sciences (ROIV) stock: analyst price target and their real reliability
Live quote · data updated Oct 14, 2026
Roivant Sciences · Health Care · ref. ETF XLV · 56 calls · price $33.35
What the company does: Roivant Sciences Ltd., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines and technologies.
📈 Roivant Sciences (ROIV) stock price
$33.35+103.4% over range
Oct 14, 25low $16.4 · high $41.81Oct 13, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
86% recommend buying · 7 analysts
📊 JPI status : Roivant Sciences has never appeared in a JPI ranking (Fair or Risk +) — our methods haven't picked it to date. See the selected stocks →
🎯 ROIV price target & analyst consensus — price $33.35
The price target · all analysts combined (7 targets)
Highest target · 1 firm of 7$55+64.9%
Median target · of 7 targets$49+46.9%
Lowest target · 1 firm of 7$46+37.9%
Current price$33.35
Where these 7 targets sit · versus the current price · 1 target per firm, last 6 months
Above the price
7100%
$40 ↔ $55
⭐ What the most reliable analysts say
· those who beat their sector, targets replayed on real prices
⭐ The most reliable of them, either direction: Guggenheim — 77% of its targets hit on this sector (53 calls tested). It aims for $46 (+38 %), call made on September 10, 2026, maturing on September 10, 2027 (34 d ago).
The 6 reliable analysts
$49+47 %
The 1 other firm
$40+20 %
How to read it: the 6 reliable firms are not filtered by optimism — 6 aim above the price, 0 below, hence their $49 median. “The 1 others” are the firms that don't pass our reliability filter on this sector.
The consensus · 7 ratings (last 6 months)
Strong Buy00%
Buy686%
Hold114%
Sell00%
Strong Sell00%
Go deeper on the analysts
🎯 ROIV price target all
All 56 calls, one by one, with our verdict on each firm.
→ See all 56 targets, analyst by analyst💡 The best analysts on ROIV most reliable
The case for and against, with the numbers, per those who've been right on the stock.
→ Should you invest in ROIV? The case for & againstAll analysts (the consensus) · vs · the best (those who've been right)
💬 A question about Roivant Sciences? The JPI assistant answers using our backtest data.
📈 Roivant Sciences fundamentals: valuation, margins & growth › open the full page
P/E —Net margin 0.0 %Revenue growth -33.5 %Not (yet) profitable
Revenue, net income and margin per year
Revenue Net income · hover a bar for details
2023
marg. -1647 %
2024
Rev +104%
2025
Rev −77%Profit −104%
2026
Rev −72%
🔎 Detailed analyses
✅ Historical analyst reliability on ROIV
Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.
| Firm ↕ | % right i ↕ | Gain vs sector i ↕ | Calls i ↕ |
|---|---|---|---|
| Citigroup ↗ | 100% | +110.0% | 4 |
| Guggenheim ↗ | 100% | +69.5% | 3 |
| JP Morgan ↗ | 100% | +51.5% | 7 |
| Piper Sandler ↗ | 100% | +0.8% | 2 |
| HC Wainwright & Co. ↗ | 81% | +49.8% | 21 |
| SVB Leerink | 80% | +74.6% | 5 |
| Cantor Fitzgerald ↗ | 78% | +21.8% | 9 |
| Jefferies ↗ | 50% | +58.4% | 2 |
| Goldman Sachs ↗ | 50% | +43.6% | 6 |
| Deutsche Bank ↗ | 50% | +2.0% | 2 |
See the other 1 firms
| Truist Securities ↗ | 40% | -7.0% | 5 |
📊 What $1,000 invested in Roivant Sciences would be worth › open the full page
In short — $1,000 invested in Roivant Sciences 10 years ago would be worth $3,568 today, i.e. +24%/yr on average. Best year: 2025 (+88%), worst: 2022 (-21%). Price performance, excluding dividends.
If I'd invested $1,000 in Roivant Sciences
| Investment | Worth today | Gain |
|---|---|---|
| 1 years ago | $3,027 | +203% |
| 3 years ago | $4,429 | +343% |
| 5 years ago | $3,480 | +248% |
Return by year (Roivant Sciences)
| Year | Return | $1,000 invested at year start |
|---|---|---|
| 2026 (YTD) | +61% | $1,614 (+61%) |
| 2025 | +88% | $3,027 (+203%) |
| 2024 | +4% | $3,151 (+215%) |
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.
📰 Recent news on Roivant Sciences
Loading news…
📋 All analyst calls on ROIV
Filtered on — · ✕ show all
Wolfe Research ↗
Oct 12, 26
■ Peer Perform neutral · not a buy
🎯 on ROIV : no call matured yet · 📊 on Health : 46.2% · +2.9% (13 calls)
in progress (365j)
matures : Oct 12, 27
matures : Oct 12, 27
▲ Buy · 🎯$51
Price at call : $39.98 — upside +28%
Today : $33.35 — upside +53%
🎯 on ROIV : no call matured yet · 📊 on Health : 48% · +12.3% (100 calls)
in progress (365j)
matures : Sep 17, 27
matures : Sep 17, 27
▲ Buy · 🎯$55
Price at call : $40.94 — upside +34%
Today : $33.35 — upside +65%
🎯 on ROIV : no call matured yet · 📊 on Health : 55.6% · +19.8% (27 calls)
in progress (365j)
matures : Sep 9, 27
matures : Sep 9, 27
Guggenheim ↗
Sep 9, 26
▲ Buy · 🎯$46
Price at call : $41.81 — upside +10%
Today : $33.35 — upside +38%
🎯 on ROIV : 100% (1 call matured) · 📊 on Health : 69.8% · +22.2% (53 calls)
in progress (365j)
matures : Sep 9, 27
matures : Sep 9, 27
HC Wainwright & Co. ↗
Sep 8, 26
▲ Buy · 🎯$47
Price at call : $41.81 — upside +12%
Today : $33.35 — upside +41%
🎯 on ROIV : 83% (12 calls matureds) · 📊 on Health : 69% · +25.4% (248 calls)
in progress (365j)
matures : Sep 8, 27
matures : Sep 8, 27
▲ Buy · 🎯$52
Price at call : $41.81 — upside +24%
Today : $33.35 — upside +56%
🎯 on ROIV : 100% (1 call matured) · 📊 on Health : 48.3% · +10.7% (116 calls)
in progress (365j)
matures : Sep 8, 27
matures : Sep 8, 27
HC Wainwright & Co. ↗
Aug 28, 26
▲ Buy · 🎯$41
Price at call : $34.71 — upside +18%
Today : $33.35 — upside +23%
🎯 on ROIV : 83% (12 calls matureds) · 📊 on Health : 69% · +25.4% (248 calls)
in progress (365j)
matures : Aug 28, 27
matures : Aug 28, 27
▲ Buy · 🎯$46
Price at call : $35.25 — upside +30%
Today : $33.35 — upside +38%
🎯 on ROIV : 100% (1 call matured) · 📊 on Health : 57% · +17.6% (128 calls)
in progress (365j)
matures : Aug 10, 27
matures : Aug 10, 27
See the other 48 calls, newest to oldest
Guggenheim ↗
Aug 7, 26
▲ Buy · 🎯$42
Price at call : $35.78 — upside +17%
Today : $33.35 — upside +26%
🎯 on ROIV : 100% (1 call matured) · 📊 on Health : 69.8% · +22.2% (53 calls)
in progress (365j)
matures : Aug 7, 27
matures : Aug 7, 27
HC Wainwright & Co. ↗
Aug 7, 26
▲ Buy · 🎯$41
Price at call : $36.34 — upside +13%
Today : $33.35 — upside +23%
🎯 on ROIV : 83% (12 calls matureds) · 📊 on Health : 69% · +25.4% (248 calls)
in progress (365j)
matures : Aug 7, 27
matures : Aug 7, 27
Guggenheim ↗
May 26, 26
▲ Buy · 🎯$36
Price at call : $29.67 — upside +21%
Today : $33.35 — upside +8%
🎯 on ROIV : 100% (1 call matured) · 📊 on Health : 69.8% · +22.2% (53 calls)
in progress (365j)
matures : May 26, 27
matures : May 26, 27
▲ Buy · 🎯$42
Price at call : $29.96 — upside +40%
Today : $33.35 — upside +26%
🎯 on ROIV : 100% (1 call matured) · 📊 on Health : 57% · +17.6% (128 calls)
in progress (365j)
matures : May 21, 27
matures : May 21, 27
▲ Buy · 🎯$41
Price at call : $29.96 — upside +37%
Today : $33.35 — upside +23%
🎯 on ROIV : no call matured yet · 📊 on Health : 55.6% · +19.8% (27 calls)
in progress (365j)
matures : May 21, 27
matures : May 21, 27
HC Wainwright & Co. ↗
May 21, 26
▲ Buy · 🎯$34
Price at call : $30.88 — upside +10%
Today : $33.35 — upside +2%
🎯 on ROIV : 83% (12 calls matureds) · 📊 on Health : 69% · +25.4% (248 calls)
in progress (365j)
matures : May 21, 27
matures : May 21, 27
Piper Sandler ↗
Apr 16, 26
▲ Overweight · 🎯$40
Price at call : $29.83 — upside +34%
Today : $33.35 — upside +20%
🎯 on ROIV : 100% (1 call matured) · 📊 on Health : 42.5% · +4.1% (120 calls)
in progress (365j)
matures : Apr 16, 27
matures : Apr 16, 27
HC Wainwright & Co. ↗
Mar 4, 26
▲ Buy · 🎯$34
Price at call : $29.52 — upside +15%
Today : $33.35 — upside +2%
🎯 on ROIV : 83% (12 calls matureds) · 📊 on Health : 69% · +25.4% (248 calls)
in progress (365j)
matures : Mar 4, 27
matures : Mar 4, 27
▲ Buy · 🎯$35
Price at call : $26.8 — upside +31%
Today : $33.35 — upside +5%
🎯 on ROIV : 100% (1 call matured) · 📊 on Health : 57% · +17.6% (128 calls)
in progress (365j)
matures : Feb 10, 27
matures : Feb 10, 27
HC Wainwright & Co. ↗
Feb 10, 26
▲ Buy · 🎯$33
Price at call : $27.35 — upside +21%
Today : $33.35 — upside -1%
🎯 on ROIV : 83% (12 calls matureds) · 📊 on Health : 69% · +25.4% (248 calls)
in progress (365j)
matures : Feb 10, 27
matures : Feb 10, 27
Guggenheim ↗
Feb 9, 26
▲ Buy · 🎯$30
Price at call : $27.35 — upside +10%
Today : $33.35 — upside -10%
🎯 on ROIV : 100% (1 call matured) · 📊 on Health : 69.8% · +22.2% (53 calls)
in progress (365j)
matures : Feb 9, 27
matures : Feb 9, 27
Leerink Partners ↗
Dec 15, 25
▲ Outperform · 🎯$32
Price at call : $22.94 — upside +39%
Today : $33.35 — upside -4%
🎯 on ROIV : 100% (1 call matured) · 📊 on Health : 58.3% · +20.9% (12 calls)
in progress (365j)
matures : Dec 15, 26
matures : Dec 15, 26
Goldman Sachs ↗
Dec 15, 25
▲ Buy · 🎯$33
Price at call : $22.94 — upside +44%
Today : $33.35 — upside -1%
🎯 on ROIV : 50% (2 calls matureds) · 📊 on Health : 59.5% · +16.1% (111 calls)
in progress (365j)
matures : Dec 15, 26
matures : Dec 15, 26
HC Wainwright & Co. ↗
Dec 12, 25
▲ Buy · 🎯$26
Price at call : $21.9 — upside +19%
Today : $33.35 — upside -22%
🎯 on ROIV : 83% (12 calls matureds) · 📊 on Health : 69% · +25.4% (248 calls)
in progress (365j)
matures : Dec 12, 26
matures : Dec 12, 26
▲ Buy · 🎯$26
Price at call : $21.32 — upside +22%
Today : $33.35 — upside -22%
🎯 on ROIV : 100% (1 call matured) · 📊 on Health : 57% · +17.6% (128 calls)
in progress (365j)
matures : Nov 11, 26
matures : Nov 11, 26
▲ Buy · 🎯$25
Price at call : $19.58 — upside +28%
Today : $33.35 — upside -25%
🎯 on ROIV : 100% (1 call matured) · 📊 on Health : 57% · +17.6% (128 calls)
in progress (365j)
matures : Oct 29, 26
matures : Oct 29, 26
Goldman Sachs ↗
Sep 18, 25
▲ Buy · 🎯$24
Price at call : $15.04 — upside +60%
Today : $33.35 — upside -28%
Expected +60% · Actual +159% · Reason (≥ +15%) : ✓ Yes
🎯 on ROIV : 50% (2 calls matureds) · 📊 on Health : 59.5% · +16.1% (111 calls)
+159.2%
stock +159% · XLV +23%
matured Sep 18, 26
▲ Buy · 🎯$20
Price at call : $15.04 — upside +33%
Today : $33.35 — upside -40%
Expected +33% · Actual +159% · Reason (≥ +15%) : ✓ Yes
🎯 on ROIV : 100% (1 call matured) · 📊 on Health : 48.3% · +10.7% (116 calls)
+159.2%
stock +159% · XLV +23%
matured Sep 18, 26
▲ Overweight · 🎯$20
Price at call : $15.09 — upside +33%
Today : $33.35 — upside -40%
Expected +33% · Actual +164% · Reason (≥ +15%) : ✓ Yes
🎯 on ROIV : 100% (1 call matured) · 📊 on Health : 49% · +7.1% (147 calls)
+163.5%
stock +164% · XLV +22%
matured Sep 18, 26
Guggenheim ↗
Sep 18, 25
▲ Buy · 🎯$21
Price at call : $15.09 — upside +39%
Today : $33.35 — upside -37%
Expected +39% · Actual +164% · Reason (≥ +15%) : ✓ Yes
🎯 on ROIV : 100% (1 call matured) · 📊 on Health : 69.8% · +22.2% (53 calls)
+163.5%
stock +164% · XLV +22%
matured Sep 18, 26
Leerink Partners ↗
Sep 18, 25
▲ Outperform · 🎯$22
Price at call : $15.09 — upside +46%
Today : $33.35 — upside -34%
Expected +46% · Actual +164% · Reason (≥ +15%) : ✓ Yes
🎯 on ROIV : 100% (1 call matured) · 📊 on Health : 58.3% · +20.9% (12 calls)
+163.5%
stock +164% · XLV +22%
matured Sep 18, 26
B of A Securities ↗
Sep 18, 25
■ Neutral neutral · not a buy · 🎯$16.5
Price at call : $15.09 — gap to target +9%
Today : $33.35 — gap to target -51%
🎯 on ROIV : no call matured yet · 📊 on Health : 64.2% · +20.2% (109 calls)
in progress (365j)
matures : Sep 18, 26
matures : Sep 18, 26
HC Wainwright & Co. ↗
Sep 18, 25
▲ Buy · 🎯$20
Price at call : $15.09 — upside +33%
Today : $33.35 — upside -40%
Expected +33% · Actual +164% · Reason (≥ +15%) : ✓ Yes
🎯 on ROIV : 83% (12 calls matureds) · 📊 on Health : 69% · +25.4% (248 calls)
+163.5%
stock +164% · XLV +22%
matured Sep 18, 26
▲ Buy · 🎯$16
Price at call : $12.39 — upside +29%
Today : $33.35 — upside -52%
Expected +29% · Actual +176% · Reason (≥ +15%) : ✓ Yes
🎯 on ROIV : 100% (1 call matured) · 📊 on Health : 57% · +17.6% (128 calls)
+175.9%
stock +176% · XLV +26%
matured Sep 2, 26
HC Wainwright & Co. ↗
Jun 18, 25
▲ Buy · 🎯$18
Price at call : $11.44 — upside +57%
Today : $33.35 — upside -46%
Expected +57% · Actual +175% · Reason (≥ +15%) : ✓ Yes
🎯 on ROIV : 83% (12 calls matureds) · 📊 on Health : 69% · +25.4% (248 calls)
+174.7%
stock +175% · XLV +12%
matured Jun 18, 26
HC Wainwright & Co. ↗
May 28, 25
▲ Buy · 🎯$18
Price at call : $10.62 — upside +69%
Today : $33.35 — upside -46%
Expected +69% · Actual +181% · Reason (≥ +15%) : ✓ Yes
🎯 on ROIV : 83% (12 calls matureds) · 📊 on Health : 69% · +25.4% (248 calls)
+181.4%
stock +181% · XLV +15%
matured May 28, 26
HC Wainwright & Co. ↗
Apr 21, 25
▲ Buy · 🎯$18
Price at call : $10.42 — upside +73%
Today : $33.35 — upside -46%
Expected +73% · Actual +180% · Reason (≥ +15%) : ✓ Yes
🎯 on ROIV : 83% (12 calls matureds) · 📊 on Health : 69% · +25.4% (248 calls)
+179.8%
stock +180% · XLV +8%
matured Apr 21, 26
HC Wainwright & Co. ↗
Feb 11, 25
▲ Buy · 🎯$18
Price at call : $10.44 — upside +72%
Today : $33.35 — upside -46%
Expected +72% · Actual +156% · Reason (≥ +15%) : ✓ Yes
🎯 on ROIV : 83% (12 calls matureds) · 📊 on Health : 69% · +25.4% (248 calls)
+156.2%
stock +156% · XLV +7%
matured Feb 11, 26
HC Wainwright & Co. ↗
Nov 13, 24
▲ Buy · 🎯$18
Price at call : $11.64 — upside +55%
Today : $33.35 — upside -46%
Expected +55% · Actual +74% · Reason (≥ +15%) : ✓ Yes
🎯 on ROIV : 83% (12 calls matureds) · 📊 on Health : 69% · +25.4% (248 calls)
+74.3%
stock +74% · XLV +5%
matured Nov 13, 25
Cantor Fitzgerald ↗
Sep 19, 24
▲ Overweight
Actual +25% · Reason (≥ +15%) : ✓ Yes
🎯 on ROIV : 78% (9 calls matureds) · 📊 on Health : 56.4% · +17.2% (117 calls)
+24.8%
stock +25% · XLV -12%
matured Sep 19, 25
HC Wainwright & Co. ↗
Sep 19, 24
▲ Buy · 🎯$18
Price at call : $11.92 — upside +51%
Today : $33.35 — upside -46%
Expected +51% · Actual +26% · Reason (≥ +15%) : ✓ Yes
🎯 on ROIV : 83% (12 calls matureds) · 📊 on Health : 69% · +25.4% (248 calls)
+26.2%
stock +26% · XLV -12%
matured Sep 19, 25
B of A Securities ↗
Sep 11, 24
■ Neutral neutral · not a buy · 🎯$12.5
Price at call : $12.38 — gap to target +1%
Today : $33.35 — gap to target -63%
🎯 on ROIV : no call matured yet · 📊 on Health : 64.2% · +20.2% (109 calls)
in progress (365j)
matures : Sep 11, 25
matures : Sep 11, 25
HC Wainwright & Co. ↗
Sep 11, 24
▲ Buy · 🎯$18
Price at call : $12.38 — upside +45%
Today : $33.35 — upside -46%
Expected +45% · Actual +16% · Reason (≥ +15%) : ✓ Yes
🎯 on ROIV : 83% (12 calls matureds) · 📊 on Health : 69% · +25.4% (248 calls)
+16.4%
stock +16% · XLV -10%
matured Sep 11, 25
Cantor Fitzgerald ↗
Sep 9, 24
▲ Overweight
Actual +8% · Reason (≥ +15%) : ✗ No
🎯 on ROIV : 78% (9 calls matureds) · 📊 on Health : 56.4% · +17.2% (117 calls)
+7.8%
stock +8% · XLV -11%
matured Sep 9, 25
HC Wainwright & Co. ↗
Aug 19, 24
▲ Buy · 🎯$18
Price at call : $11.49 — upside +57%
Today : $33.35 — upside -46%
Expected +57% · Actual +2% · Reason (≥ +15%) : ✗ No
🎯 on ROIV : 83% (12 calls matureds) · 📊 on Health : 69% · +25.4% (248 calls)
+2.4%
stock +2% · XLV -11%
matured Aug 19, 25
Piper Sandler ↗
Jul 10, 24
▲ Overweight · 🎯$22
Price at call : $11.24 — upside +96%
Today : $33.35 — upside -34%
Expected +96% · Actual +1% · Reason (≥ +15%) : ✗ No
🎯 on ROIV : 100% (1 call matured) · 📊 on Health : 42.5% · +4.1% (120 calls)
+1.1%
stock +1% · XLV -8%
matured Jul 10, 25
Cantor Fitzgerald ↗
Jun 18, 24
▲ Overweight
Actual +6% · Reason (≥ +15%) : ✗ No
🎯 on ROIV : 78% (9 calls matureds) · 📊 on Health : 56.4% · +17.2% (117 calls)
+6.0%
stock +6% · XLV -9%
matured Jun 18, 25
HC Wainwright & Co. ↗
May 31, 24
▲ Buy · 🎯$18
Price at call : $10.36 — upside +74%
Today : $33.35 — upside -46%
Expected +74% · Actual +8% · Reason (≥ +15%) : ✗ No
🎯 on ROIV : 83% (12 calls matureds) · 📊 on Health : 69% · +25.4% (248 calls)
+7.8%
stock +8% · XLV -8%
matured May 31, 25
HC Wainwright & Co. ↗
Apr 22, 24
▲ Buy · 🎯$18
Price at call : $10.6 — upside +70%
Today : $33.35 — upside -46%
Expected +70% · Actual -2% · Reason (≥ +15%) : ✗ No
🎯 on ROIV : 83% (12 calls matureds) · 📊 on Health : 69% · +25.4% (248 calls)
-1.7%
stock -2% · XLV -3%
matured Apr 22, 25
Goldman Sachs ↗
Apr 3, 24
▲ Buy · 🎯$18
Price at call : $11.51 — upside +56%
Today : $33.35 — upside -46%
Expected +56% · Actual -18% · Reason (≥ +15%) : ✗ No
🎯 on ROIV : 50% (2 calls matureds) · 📊 on Health : 59.5% · +16.1% (111 calls)
-17.8%
stock -18% · XLV -5%
matured Apr 3, 25
HC Wainwright & Co. ↗
Apr 3, 24
▲ Buy · 🎯$18
Price at call : $11.51 — upside +56%
Today : $33.35 — upside -46%
Expected +56% · Actual -13% · Reason (≥ +15%) : ✗ No
🎯 on ROIV : 83% (12 calls matureds) · 📊 on Health : 69% · +25.4% (248 calls)
-13.0%
stock -13% · XLV -1%
matured Apr 3, 25
Deutsche Bank ↗
Apr 3, 24
▲ Buy · 🎯$15
Price at call : $11.51 — upside +30%
Today : $33.35 — upside -55%
Expected +30% · Actual -13% · Reason (≥ +15%) : ✗ No
🎯 on ROIV : 0% (1 call matured) · 📊 on Health : 53.8% · +9.7% (80 calls)
-13.0%
stock -13% · XLV -1%
matured Apr 3, 25
Cantor Fitzgerald ↗
Sep 18, 23
▲ Overweight · 🎯$15
Price at call : $11.12 — upside +35%
Today : $33.35 — upside -55%
Expected +35% · Actual +8% · Reason (≥ +15%) : ✗ No
🎯 on ROIV : 78% (9 calls matureds) · 📊 on Health : 56.4% · +17.2% (117 calls)
+8.4%
stock +8% · XLV +18%
matured Sep 17, 24
Cantor Fitzgerald ↗
Sep 5, 23
▲ Overweight · 🎯$15
Price at call : $11.75 — upside +28%
Today : $33.35 — upside -55%
Expected +28% · Actual +0% · Reason (≥ +15%) : ✗ No
🎯 on ROIV : 78% (9 calls matureds) · 📊 on Health : 56.4% · +17.2% (117 calls)
0.0%
stock +0% · XLV +18%
matured Sep 4, 24
Cantor Fitzgerald ↗
Aug 31, 23
▲ Overweight · 🎯$15
Price at call : $11.57 — upside +30%
Today : $33.35 — upside -55%
Expected +30% · Actual +6% · Reason (≥ +15%) : ✗ No
🎯 on ROIV : 78% (9 calls matureds) · 📊 on Health : 56.4% · +17.2% (117 calls)
+5.7%
stock +6% · XLV +18%
matured Aug 30, 24
Cantor Fitzgerald ↗
Aug 22, 23
▲ Overweight · 🎯$15
Price at call : $11.71 — upside +28%
Today : $33.35 — upside -55%
Expected +28% · Actual -0% · Reason (≥ +15%) : ✗ No
🎯 on ROIV : 78% (9 calls matureds) · 📊 on Health : 56.4% · +17.2% (117 calls)
-0.3%
stock -0% · XLV +16%
matured Aug 21, 24
Cantor Fitzgerald ↗
Jun 20, 23
▲ Overweight · 🎯$15
Price at call : $9.79 — upside +53%
Today : $33.35 — upside -55%
Expected +53% · Actual +10% · Reason (≥ +15%) : ✗ No
🎯 on ROIV : 78% (9 calls matureds) · 📊 on Health : 56.4% · +17.2% (117 calls)
+10.3%
stock +10% · XLV +11%
matured Jun 19, 24
Cantor Fitzgerald ↗
Apr 29, 22
▲ Overweight · 🎯$15
Price at call : $3.69 — upside +307%
Today : $33.35 — upside -55%
Expected +307% · Actual +134% · Reason (≥ +15%) : ✓ Yes
🎯 on ROIV : 78% (9 calls matureds) · 📊 on Health : 56.4% · +17.2% (117 calls)
+133.6%
stock +134% · XLV +3%
matured Apr 29, 23
Frequently asked questions
Should I buy Roivant Sciences stock?
This isn't buy advice. For Roivant Sciences, the analyst consensus is "Buy", with an average price target of $49.00 (+47% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 100% of the time (4 calls tracked on Roivant Sciences). We show the numbers — you decide.
Is it too late to buy Roivant Sciences? How high can it go?
The most bullish analyst target on Roivant Sciences is $55.00 (+65% above today's price); the average is $49.00. That's the upside they see. Check how reliable those analysts have actually been on Roivant Sciences on our site before trusting it.
Is Roivant Sciences still a good buy?
The most useful "opinion" isn't an opinion — it's a track record: 11 analysts have a real record on Roivant Sciences, the best hitting 100% over 4 calls. Current consensus: "Buy". Make your call on data, not noise.
Should you invest in Roivant Sciences? The case for and against
The arguments for and against, one by one, from the numbers: why invest in ROIV (and why hesitate).
What has Roivant Sciences's past performance been?
Historical returns and a "how much if I had invested" calculator: ROIV performance & returns.
BIIB 
VRTX 
REGN 
UNH 
EW 
SRPT 
VEEV 
BSX